Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US.
Publication
, Journal Article
Jarlenski, M; Chen, Q; Gao, A; Rothenberger, SD; Krans, EE
Published in: JAMA network open
April 2022
Duke Scholars
Published In
JAMA network open
DOI
EISSN
2574-3805
ISSN
2574-3805
Publication Date
April 2022
Volume
5
Issue
4
Start / End Page
e227964
Related Subject Headings
- Pregnancy
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Methadone
- Humans
- Female
- Drug Overdose
- Buprenorphine
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jarlenski, M., Chen, Q., Gao, A., Rothenberger, S. D., & Krans, E. E. (2022). Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US. JAMA Network Open, 5(4), e227964. https://doi.org/10.1001/jamanetworkopen.2022.7964
Jarlenski, Marian, Qingwen Chen, Alice Gao, Scott D. Rothenberger, and Elizabeth E. Krans. “Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US.” JAMA Network Open 5, no. 4 (April 2022): e227964. https://doi.org/10.1001/jamanetworkopen.2022.7964.
Jarlenski M, Chen Q, Gao A, Rothenberger SD, Krans EE. Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US. JAMA network open. 2022 Apr;5(4):e227964.
Jarlenski, Marian, et al. “Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US.” JAMA Network Open, vol. 5, no. 4, Apr. 2022, p. e227964. Epmc, doi:10.1001/jamanetworkopen.2022.7964.
Jarlenski M, Chen Q, Gao A, Rothenberger SD, Krans EE. Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US. JAMA network open. 2022 Apr;5(4):e227964.
Published In
JAMA network open
DOI
EISSN
2574-3805
ISSN
2574-3805
Publication Date
April 2022
Volume
5
Issue
4
Start / End Page
e227964
Related Subject Headings
- Pregnancy
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Methadone
- Humans
- Female
- Drug Overdose
- Buprenorphine
- 42 Health sciences
- 32 Biomedical and clinical sciences